Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2019 | 07-2019 | 04-2019 | 01-2019 | 10-2018 | |
| Sales | 7,625 | 6,737 | 7,719 | 6,430 | 6,693 |
| Cost of Goods | 3,881 | 3,752 | 4,302 | 3,429 | 3,451 |
| Gross Profit | 3,744 | 2,985 | 3,417 | 3,001 | 3,242 |
| Operating Expenses | 4,334 | 4,351 | 3,835 | 3,800 | 3,418 |
| Operating Income | 291 | -614 | -116 | -370 | 275 |
| Other Income | 27 | -12 | -34 | 1 | -7 |
| Pre-tax Income | 318 | -626 | -150 | -369 | 268 |
| Income Tax | 11 | 15 | 102 | N/A | 1 |
| Net Income Continuous | 307 | -641 | -252 | -369 | 267 |
| Net Income | $307 | $-641 | $-252 | $-369 | $267 |
| EPS Basic Total Ops | 0.03 | -0.06 | -0.02 | -0.03 | 0.02 |
| EPS Basic Continuous Ops | 0.03 | -0.06 | -0.02 | -0.03 | 0.02 |
| EPS Diluted Total Ops | 0.02 | -0.06 | -0.02 | -0.03 | 0.02 |
| EPS Diluted Continuous Ops | 0.02 | -0.06 | -0.02 | -0.03 | 0.02 |
| EBITDA(a) | $469 | $-432 | $57 | $-206 | $426 |